Story thread · 3 reports / 2 sources

XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™

financialpost.com · 4dShare

● Contract manufacturing of GMP drug substance and commercial-scale tablets to support the XRX-OXY-102 clinical study and future US FDA marketing approval ● CALGARY, Alberta, Sept. 10, 2026 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive […]

First report: XORTX Re-Engages Investor Relations Program — thestar.com, 6d